Device

Wenemea has developed a phase zero prototype and has passed proof of concept. The prototype can deliver basic results.

Upon the prototype we will develop, design and manufacture a small and relative low cost tool for measuring nerves’ function.

Data model

Wenemea will develop a data model based AI/machine learning that predicts the risk of developing peripheral neuropathy for a given neurological measurement.